The Danish-based biotech company, Novozymes, has launched a new product called Saphera. Saphera is an improved lactase enzyme that sets a new standard for production and quality for a range of lactose-free products.
What makes Saphera different from other lactase enzymes?
Saphera is made from Bifidobacterium bifidum, in contrast to traditional lactase which is made from yeast. Saphera helps in achieving the desired lactose level accurately, precisely and easily. This is due to fewer oligosaccharides – carbohydrates are formed during the reaction compared to yeast lactases, particularly when producing 0.01% lactose-free milk. Additionally, Saphera converts lactose into glucose and glucose. This means that the dairy producer can reduce the amount of sugar added and achieve the same sweetness in their products.
“Saphera works at lower pH and higher temperature than other lactases and is therefore not only suitable for the production of lactose-free milk and other products, but also for fermented dairy products. It works extremely well in yogurt production – better than conventional yeast-based lactases. In addition, the lack of invertase and other critical side activities makes Saphera a great solution in sweetened dairy products, maintaining physical and organoleptic properties during shelf life better than any other product on the market”, says Lyndegaard (Director at Novozymes)
There is massive demand for lactose-free products
Lactose intolerance affects millions of people across the globe. The demand for lactose-free products has risen globally especially in areas with emerging markets. Health conscious consumers have increased significantly over the last decade. This has resulted in moving lactose-free products from the specialty segment to mainstream. The demand for lactose-free products prompted the development of lactose-free products.
“Our goal was to address some of the key issues driving the lactose-free dairy market. The rapidly expanding market for lactose-free dairy products necessitates a trouble-free easy production for the strongly expanding volumes of lactose-free dairy products. Also, the fermented dairy products are increasingly receiving interest as healthy foods from consumers. Better production control and better suitability for fermented dairy products were key areas of focus when developing Saphera”, explains Lyndegaard
Quick Facts about Saphera:
- Saphera is applicable for a broad range of dairy products including fresh, ESL and UHT milk, milk drinks, cream, ice cream, fermented dairy products and dulce de leche. Saphera is available in a variety of formulations to meet varying processing needs.
- Saphera is sold as a liquid standard product (Saphera 2600 L) for use in batch process and in in-line dosing systems (i.e. TetraPak Aldose). It is sold as a sterile liquid product (Saphera 900 LS) for use in aseptic in-line dosing systems (i.e. TetraPak FlexDos).
With the development of Saphera we will be expecting a great expansion of lactose-free products on the market. Hopefully with lactose-free products becoming less specialised and more mainstream, the cost of lactose-free decreases.
What do you think about Saphera? Share your thoughts in the comment section below.